You’re not alone. You’re taking the right steps to get the relief you seek, but it’s only natural to want to know every detail before getting started. You can find everything you need to know, right here.
Discover how Medtronic can help you get more out of life.
A: This therapy is an implantable device that targets the nerves that control your bladder to help it function normally again.
A: Both are designed to deliver effective symptom relief through sacral neuromodulation. The InterStim X™ system is a recharge-free device, while the InterStim™ Micro system is rechargeable.
A: Medtronic bladder control therapy delivered by the InterStim™ systems restores bladder function by gently stimulating the sacral nerves.*
A: Doctors believe that bladder control problems are caused by miscommunication between the brain and the sacral nerves, which are located in the lower back and control the bladder.1
A: With this therapy, you may experience fewer trips to the bathroom, fewer accidents, more confidence, and more freedom.2
A: Choosing to have an InterStim™ system implanted has risks similar to any surgical procedure, including swelling, bruising, bleeding, and infection. Talk with your doctor about ways to minimize these risks.†
A: No. It can be effective, but it’s not a cure. If the neurostimulator is turned off or removed, symptoms can return.
A: Everyone's experience of relief is different, so it is difficult to generalize. What we can say is that in a clinical study, our therapy significantly reduced symptoms of overactive bladder (OAB) and non-obstructive urinary retention in people treated for five years.†,3,4
A: Most people describe it as a slight pulling, tingling, or fluttering sensation in the pelvic area. The stimulation is always adjustable, and should not be painful.
A: You can try it before you decide, and it's reversible if you change your mind later. The InterStim™ systems deliver sacral neuromodulation (SNM) therapy that has been shown to be more effective than medications for OAB.‡,5 And unlike injections, this therapy doesn’t require self-catheterization or repeated treatment visits.
A: Yes, you can have a full-body MRI scan under certain conditions. Your clinician can provide more details about these conditions, as well as safety information.§
A: Since its approval in 1997, the InterStim™ system has been used to treat bladder control problems in hundreds of thousands of patients around the world.
A: Medicare and many private insurance companies cover this therapy. Talk to your doctor to learn more about your insurance coverage.
With the InterStim™ systems, restored bladder function is defined as a 50% or greater reduction in your troublesome bladder symptoms.
In addition to risks related to surgery, complications can include pain at the implant sites, new pain, infection, lead (thin wire) movement/migration, device problems, undesirable changes in urinary or bowel function, and uncomfortable stimulation (sometimes described as a jolting or shocking feeling). Talk with your doctor about ways to minimize these risks.
Under certain conditions.
Leng WW, Morrisroe SN. Sacral nerve stimulation for the overactive bladder. Urol Clin N Am. 2006;33:491–501.
Siegel S, Noblett K, Mangel J, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim® Therapy compared to standard medical therapy at six months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015;34:224–230. DOI: 10.1002/nau.22544
Siegel S, Noblett K, Mangel J, et al. Five-year follow-up results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. Journal of Urology. 2018;Volume 199(1), 229–236.
Van Kerrebroeck P, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. Journal of Urology. 2007;178:2029-2034.
Siegel S, Noblett K, Mangel J, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim® Therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015;34:224–230.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.